Buzz Stocks: Honeywell International Inc., Evoke Pharma Inc, and Gilead Sciences, Inc.

Today's stocks to watch in the news include Honeywell International Inc. (NYSE:HON), Evoke Pharma Inc (NASDAQ:EVOK), and Gilead Sciences, Inc. (NASDAQ:GILD)

Dec 16, 2016 at 9:28 AM
facebook X logo linkedin


U.S. stock futures are higher this morning, putting Dow 20,000 in focus. Among specific equities in the spotlight today are manufacturing stock Honeywell International Inc. (NYSE:HON), as well as biotechs Evoke Pharma Inc (NASDAQ:EVOK) and Gilead Sciences, Inc. (NASDAQ:GILD). Here's a quick look at what's driving HON, EVOK, and GILD.

  • A disappointing full-year outlook has HON pointed 1.8% lower in electronic trading. The shares would remain atop their rising 200-day moving average on such a move, however, after closing Thursday at $116.34 -- up 13% in 2016. But, if Honeywell International Inc. does breach the 200-day and losses mount, the stock could fall victim to bearish analyst attention. Fourteen of 16 brokerage firms recommend buying HON shares, while zero consider a "sell." 

  • EVOK is up over 40% in pre-market trading, after the Food and Drug Administration (FDA) gave its lead drug, Gimoti, positive application guidance. Even if these gains come to fruition, the stock will be sitting far below its July peak of $11.11, closing Thursday at $1.44. Evoke Pharma Inc short sellers would like to see the downtrend resume. Despite a 18.6% decline during the last two reporting periods, short interest represents 13.2% of the stock's float, equating to more than a week's worth of buying power, according to average daily volumes.  

  • GILD is down 1.7% ahead of the open, after a jury awarded Merck & Co., Inc. (NYSE:MRK) roughly $2.5 billion in royalties in the companies' patent dispute. Gilead Sciences, Inc. has been trending lower throughout the year, underperforming the S&P 500 Index (SPX) by 11 percentage points during the past three months to trade at $75.55. Despite the stock's struggles, options traders have been overwhelmingly bullish. For instance, GILD's 10-day call/put volume ratio of 5.70 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks in the 99th annual percentile. 

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI